Search research articles
Contact Us
Filters
Showing results (171-180 of 237) with videos related to
Page
of 24
Sort By:
Journal of Alzheimer'S Disease : JAD
|
February 13, 2023
Cerebrospinal Fluid Panel of Synaptic Proteins in Cerebral Amyloid Angiopathy and Alzheimer's Disease
Emma van den Berg, Johanna Nilsson, Iris Kersten, et al.
Journal of Inherited Metabolic Disease
|
October 9, 2020
Clinical presentation and long-term follow-up of dopamine beta hydroxylase deficiency
Tessa Wassenberg, Jaap Deinum, Frans J van Ittersum, et al.
Journal of Neurochemistry
|
January 11, 2016
Validation of soluble amyloid-β precursor protein assays as diagnostic CSF biomarkers for neurodegenerative diseases
Linda J C van Waalwijk van Doorn, Marleen J Koel-Simmelink, Ute Haußmann, et al.
Annals of Neurology
|
April 16, 2024
Divergent Associations of Slow-Wave Sleep versus Rapid Eye Movement Sleep with Plasma Amyloid-Beta
Yevgenia Rosenblum, Mariana Pereira, Oliver Stange, et al.
European Journal of Immunology
|
March 6, 2021
Human type 1 and type 2 conventional dendritic cells express indoleamine 2,3-dioxygenase 1 with functional effects on T cell priming
Simone P Sittig, Jasper J P van Beek, Georgina Flórez-Grau, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
April 28, 2022
Serum GFAP differentiates Alzheimer's disease from frontotemporal dementia and predicts MCI-to-dementia conversion
Patrick Oeckl, Sarah Anderl-Straub, Christine A F Von Arnim, et al.
Alzheimer'S Research & Therapy
|
May 4, 2024
The relation of a cerebrospinal fluid profile associated with Alzheimer's disease with cognitive function and neuropsychiatric symptoms in sporadic cerebral amyloid angiopathy
Anna M De Kort, Kanishk Kaushik, H Bea Kuiperij, et al.
Alzheimer'S Research & Therapy
|
June 3, 2023
Plasma amyloid beta 42 is a biomarker for patients with hereditary, but not sporadic, cerebral amyloid angiopathy
Anna M de Kort, H Bea Kuiperij, Lieke Jäkel, et al.
Human Genetics
|
August 9, 2012
Linkage analysis for plasma amyloid beta levels in persons with hypertension implicates Aβ-40 levels to presenilin 2
Carla A Ibrahim-Verbaas, Irina V Zorkoltseva, Najaf Amin, et al.
Plos One
|
May 5, 2012
Human prion diseases in the Netherlands (1998-2009): clinical, genetic and molecular aspects
Casper Jansen, Piero Parchi, Sabina Capellari, et al.
Page
of 24
Search research articles
Search
Showing results (171-180 of 237) with videos related to
Sort By:
Page
of 24
Journal of Alzheimer'S Disease : JAD
|
February 13, 2023
Cerebrospinal Fluid Panel of Synaptic Proteins in Cerebral Amyloid Angiopathy and Alzheimer's Disease
Emma van den Berg, Johanna Nilsson, Iris Kersten, et al.
Journal of Inherited Metabolic Disease
|
October 9, 2020
Clinical presentation and long-term follow-up of dopamine beta hydroxylase deficiency
Tessa Wassenberg, Jaap Deinum, Frans J van Ittersum, et al.
Journal of Neurochemistry
|
January 11, 2016
Validation of soluble amyloid-β precursor protein assays as diagnostic CSF biomarkers for neurodegenerative diseases
Linda J C van Waalwijk van Doorn, Marleen J Koel-Simmelink, Ute Haußmann, et al.
Annals of Neurology
|
April 16, 2024
Divergent Associations of Slow-Wave Sleep versus Rapid Eye Movement Sleep with Plasma Amyloid-Beta
Yevgenia Rosenblum, Mariana Pereira, Oliver Stange, et al.
European Journal of Immunology
|
March 6, 2021
Human type 1 and type 2 conventional dendritic cells express indoleamine 2,3-dioxygenase 1 with functional effects on T cell priming
Simone P Sittig, Jasper J P van Beek, Georgina Flórez-Grau, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
April 28, 2022
Serum GFAP differentiates Alzheimer's disease from frontotemporal dementia and predicts MCI-to-dementia conversion
Patrick Oeckl, Sarah Anderl-Straub, Christine A F Von Arnim, et al.
Alzheimer'S Research & Therapy
|
May 4, 2024
The relation of a cerebrospinal fluid profile associated with Alzheimer's disease with cognitive function and neuropsychiatric symptoms in sporadic cerebral amyloid angiopathy
Anna M De Kort, Kanishk Kaushik, H Bea Kuiperij, et al.
Alzheimer'S Research & Therapy
|
June 3, 2023
Plasma amyloid beta 42 is a biomarker for patients with hereditary, but not sporadic, cerebral amyloid angiopathy
Anna M de Kort, H Bea Kuiperij, Lieke Jäkel, et al.
Human Genetics
|
August 9, 2012
Linkage analysis for plasma amyloid beta levels in persons with hypertension implicates Aβ-40 levels to presenilin 2
Carla A Ibrahim-Verbaas, Irina V Zorkoltseva, Najaf Amin, et al.
Plos One
|
May 5, 2012
Human prion diseases in the Netherlands (1998-2009): clinical, genetic and molecular aspects
Casper Jansen, Piero Parchi, Sabina Capellari, et al.
Page
of 24